Zymeworks Net Income 2016-2022 | ZYME
Zymeworks net income from 2016 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Zymeworks Annual Net Income
(Millions of US $) |
| 2021 |
$-212 |
| 2020 |
$-181 |
| 2019 |
$-145 |
| 2018 |
$-37 |
| 2017 |
$-11 |
| 2016 |
$-34 |
| 2015 |
$-19 |
Zymeworks Quarterly Net Income
(Millions of US $) |
| 2022-06-30 |
$-65 |
| 2022-03-31 |
$-73 |
| 2021-12-31 |
$-39 |
| 2021-09-30 |
$-61 |
| 2021-06-30 |
$-68 |
| 2021-03-31 |
$-45 |
| 2020-12-31 |
$-38 |
| 2020-09-30 |
$-73 |
| 2020-06-30 |
$-39 |
| 2020-03-31 |
$-31 |
| 2019-12-31 |
$-72 |
| 2019-09-30 |
$-30 |
| 2019-06-30 |
$-29 |
| 2019-03-31 |
$-14 |
| 2018-12-31 |
$9 |
| 2018-09-30 |
$-19 |
| 2018-06-30 |
$-6 |
| 2018-03-31 |
$-21 |
| 2017-12-31 |
$33 |
| 2017-09-30 |
$-16 |
| 2017-06-30 |
$-11 |
| 2017-03-31 |
$-16 |
| 2016-12-31 |
$-11 |
| 2016-09-30 |
$-12 |
| 2016-06-30 |
$-7 |
| 2016-03-31 |
$-3 |
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.614B |
$0.027B |
|
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|
